Infectious disease readiness depends on rehearsed workflows, bidirectional public health communication, and rapid access to care.
|Articles|December 10, 2007
New trials may cut clopidogrel use
A trio of late-breaking clinical trials could change standard drug treatment for patients undergoing percutaneous coronary intervention, or PCI.
Advertisement
Advertisement
Related to this article
Pharmacist pain clinics typically focus on comprehensive medication management involving the entire patient scenario.
A case shows a suspected recurrence of pneumococcal disease that ended with removal of one cochlear implant and replacement of the other.
Detailed phase 3 data show retatrutide lowered body weight and A1C over 80 weeks for patients with diabetes and obesity.
In celebration of the organization’s recent convention, NCPA released its annual digest report for members, providing a detailed overview of independent community pharmacy.
Local collaborations can turn pharmacies into care-coordination hubs, but lasting results require trained teams, shared data, and sustainable payment.
In a rapidly evolving diabetes and obesity management landscape, Brian Smith, PharmD, discusses approaches that are helping patients maximize their outcomes on GLP-1 therapy.
A structured recommendation workflow at a community pharmacy was associated with more multivaccine patients than routine practice.
Advertisement
Advertisement
Trending on Drug Topics
1
From Binder to Action: Making Infectious Disease Outbreak Plans Operational
2
Retatrutide Delivers 20.8% Weight Loss in Adults With Type 2 Diabetes
3
Diabetes Medication Adherence Lags for Black and Hispanic Medicare Patients
4
Independent Pharmacies Remain Resilient, Essential Community Providers | NCPA 2026
5